TXUE yields 1.06% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, TXUE + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TXUE + MRK for your $10,000?
TXUE opportunistically constructs a portfolio of 50-55 non-US large-cap issuers across sectors and developed markets. Investments consist of basic value stocks, consistent earners, and emerging franchises. The objective is to optimize risk-adjusted returns by identifying undervalued companies with strong fundamentals, including those mispriced due to unfavorable market perceptions or industry-specific challenges. Positions are based on bottom-up fundamental analysis of company-specific factors, complemented by macroeconomic insights on interest rates, inflation, and geopolitical trends. While predominantly focused on large-cap stocks, the fund may invest across all capitalizations. The fund may use derivatives, such as currency forwards, to hedge foreign currency exposure.
Full TXUE Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.